Cours Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Actions
IL0006290147
Produits pharmaceutiques
CA 2024 * | 15,95 Md 59,3 Md 14,49 Md | CA 2025 * | 16,52 Md 61,4 Md 15 Md | Capitalisation | 18,41 Md 68,41 Md 16,71 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 820 M 3,05 Md 745 M | Résultat net 2025 * | 1,39 Md 5,16 Md 1,26 Md | VE / CA 2024 * | 2,09 x |
Dette nette 2024 * | 14,93 Md 55,47 Md 13,55 Md | Dette nette 2025 * | 12,41 Md 46,12 Md 11,27 Md | VE / CA 2025 * | 1,87 x |
PER 2024 * |
17,3
x | PER 2025 * |
12
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 89,71% |
Dernier transcript sur Teva Pharmaceutical Industries Limited
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01/01/23 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22/12/19 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01/09/15 |
Janet Vergis
BRD | Director/Board Member | 59 | 09/06/20 |
Sol Barer
CHM | Chairman | 76 | 01/01/15 |
Varia. 1 janv. | Capi. | |
---|---|---|
+29,43% | 684 Md | |
+30,34% | 568 Md | |
-3,99% | 361 Md | |
+17,61% | 329 Md | |
+3,91% | 284 Md | |
+16,21% | 240 Md | |
+9,66% | 208 Md | |
-6,83% | 200 Md | |
+6,73% | 166 Md |